Related Experiment Videos
[Uterine sarcoma. Clinical and pathological study of 25 cases]
G Zacchè1, L Zanoio, P Sommacampagna
1Divisione di Ostetricia e Ginecologia, Università degli Studi di Verona.
Minerva Ginecologica
|July 1, 1992
Summary
This study on uterine sarcoma found that leiomyosarcoma was the most common type. Survival rates after three years were significantly lower for advanced stages of uterine sarcoma.
Area of Science:
- Gynecology
- Oncology
- Pathology
Context:
- Uterine sarcoma is a rare and aggressive malignancy.
- Early diagnosis and treatment are crucial for patient outcomes.
- This study reviews a cohort of uterine sarcoma cases from a specific period.
Purpose:
- To report on the follow-up and outcomes of 25 uterine sarcoma cases.
- To analyze the distribution of uterine sarcoma subtypes.
- To identify initial symptoms and diagnostic pathways.
Summary:
- The study included 25 uterine sarcoma cases (1979-1988), predominantly leiomyosarcoma (56%).
- Patients were mainly aged 40-70, multiparous, and in menopause at diagnosis.
- Metrorrhagia was the primary symptom in 72% of cases, often diagnosed post-surgery.
- Most surgical interventions were combined with chemotherapy and/or radiotherapy.
Impact:
- Survival rates after three years were 66.6% for stage I and 33.4% for stage II.
- No survivors were reported for stage III uterine sarcoma at the three-year mark.
- Highlights the importance of timely diagnosis and multimodal treatment for uterine sarcoma.